Amount of claims against entity

No definition available.

Name:	azn_AmountOfClaimsAgainstEntity
Namespace Prefix:	azn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Court decision on amount of milestone that had been reached.

+ References

No definition available.

+ Details

Name:	azn_CourtDecisionOnAmountOfMilestoneThatHadBeenReached
Namespace Prefix:	azn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Damages awarded, value.

+ References

No definition available.

+ Details

Name:	azn_DamagesAwardedValue
Namespace Prefix:	azn_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Litigation settlement, amount awarded to counterparty

+ References

No definition available.

+ Details

Name:	azn_LitigationSettlementAmountAwardedToCounterparty
Namespace Prefix:	azn_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Number of appeals prior to dismissal.

+ References

No definition available.

+ Details

Name:	azn_NumberOfAppealsPriorToDismissal
Namespace Prefix:	azn_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of generic manufacturers which settlement agreements have been entered with.

+ References

No definition available.

+ Details

Name:	azn_NumberOfGenericManufacturersWhichSettlementAgreementsHaveBeenEnteredWith
Namespace Prefix:	azn_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of generic manufacturers whose claims have been dismissed

+ References

No definition available.

+ Details

Name:	azn_NumberOfGenericManufacturersWhoseClaimsHaveBeenDismissed
Namespace Prefix:	azn_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of generic manufacturers with which proceedings are ongoing

+ References

No definition available.

+ Details

Name:	azn_NumberOfGenericManufacturersWithWhichProceedingsAreOngoing
Namespace Prefix:	azn_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of patents being challenged.

+ References

No definition available.

+ Details

Name:	azn_NumberOfPatentsBeingChallenged
Namespace Prefix:	azn_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Ratio of possible fine to amount of unpaid taxes.

+ References

No definition available.

+ Details

Name:	azn_RatioOfPossibleFineToAmountOfUnpaidTaxes
Namespace Prefix:	azn_
Data Type:	xbrli:decimalItemType
Balance Type:	na
Period Type:	instant

- Definition

Stay period for approval of each defendant's product

+ References

No definition available.

+ Details

Name:	azn_StayPeriodForApprovalOfEachDefendantSProduct
Namespace Prefix:	azn_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Suspected unpaid importation taxes.

+ References

No definition available.

+ Details

Name:	azn_SuspectedUnpaidImportationTaxes
Namespace Prefix:	azn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.

+ References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfContingentLiabilitiesLineItems
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	azn_ClassesOfContingentAssetsAxis=azn_LokelmaUsPatentProceedingsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	azn_ClassesOfContingentAssetsAxis=azn_SolirisCanadaPatentProceedingsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_ClassesOfProvisionsAxis=azn_SeroquelXrAntitrustLitigationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_CounterpartiesAxis=azn_RussianMinistryOfHealthMohMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	azn_ClassesOfContingentAssetsAxis=azn_TagrissoPatentProceedingsRussiaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_ClassesOfContingentLiabilitiesAxis=azn_DefiniensCommercialLitigationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_ClassesOfContingentLiabilitiesAxis=azn_ShenzhenCityCustomsOfficeProceedingsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_ClassesOfContingentLiabilitiesAxis=azn_ForxigaUkPatentProceedingsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_ClassesOfContingentLiabilitiesAxis=azn_SyntimmuneMilestoneLitigationUsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Legal proceedings and contingent liabilities - Legal proceedings (Details) $ in Millions	1 Months Ended								35 Months Ended
	Jun. 30, 2025 USD ($) patent	May 31, 2025 USD ($)	Sep. 30, 2024 USD ($)	Jul. 31, 2024	Dec. 31, 2023 USD ($)	Sep. 30, 2023	Aug. 31, 2022	Jul. 31, 2022	Jun. 30, 2025 patent	Apr. 30, 2025 USD ($)	Jul. 31, 2020 USD ($)
Lokelma US patent proceedings
Commitments and contingent liabilities
Number of generic manufacturers which settlement agreements have been entered with									5
Number of generic manufacturers with which proceedings are ongoing							5
Soliris Canada patent proceedings
Commitments and contingent liabilities
Stay period for approval of each defendant's product						24 months
Seroquel XR Antitrust Litigation
Commitments and contingent liabilities
Litigation settlement, amount awarded to counterparty		$ 97.0
Number of generic manufacturers whose claims have been dismissed								1
Number of generic manufacturers which settlement agreements have been entered with			1
Russian Ministry of Health (MOH) \| Tagrisso Patent Proceedings, Russia
Commitments and contingent liabilities
Number of appeals prior to dismissal				2
Definiens commercial litigation
Commitments and contingent liabilities
Amount of claims against entity											$ 140.0
Damages awarded, value					$ 46.0
Shenzhen City Customs Office proceedings
Commitments and contingent liabilities
Suspected unpaid importation taxes										$ 1.6
Shenzhen City Customs Office proceedings \| Minimum
Commitments and contingent liabilities
Ratio of possible fine to amount of unpaid taxes										1
Shenzhen City Customs Office proceedings \| Maximum
Commitments and contingent liabilities
Ratio of possible fine to amount of unpaid taxes										5
Forxiga UK patent proceedings
Commitments and contingent liabilities
Number of patents being challenged \| patent	1								1
Syntimmune Milestone Litigation, US
Commitments and contingent liabilities
Damages awarded, value	$ 181.0
Court decision on amount of milestone that had been reached			$ 130.0